These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 1657465)
21. Induction of nitric oxide synthase during Japanese encephalitis virus infection: evidence of protective role. Saxena SK; Mathur A; Srivastava RC Arch Biochem Biophys; 2001 Jul; 391(1):1-7. PubMed ID: 11414678 [TBL] [Abstract][Full Text] [Related]
22. A Japanese Encephalitis Virus Vaccine Inducing Antibodies Strongly Enhancing In Vitro Infection Is Protective in Pigs. García-Nicolás O; Ricklin ME; Liniger M; Vielle NJ; Python S; Souque P; Charneau P; Summerfield A Viruses; 2017 May; 9(5):. PubMed ID: 28531165 [TBL] [Abstract][Full Text] [Related]
23. Enhanced immune responses against Japanese encephalitis virus using recombinant adenoviruses coexpressing Japanese encephalitis virus envelope and porcine interleukin-6 proteins in mice. Liu H; Wu R; Liu K; Yuan L; Huang X; Wen Y; Ma X; Yan Q; Zhao Q; Wen X; Cao S Virus Res; 2016 Aug; 222():34-40. PubMed ID: 27235810 [TBL] [Abstract][Full Text] [Related]
24. Endothelial Japanese encephalitis virus infection enhances migration and adhesion of leukocytes to brain microvascular endothelia via MEK-dependent expression of ICAM1 and the CINC and RANTES chemokines. Lai CY; Ou YC; Chang CY; Pan HC; Chang CJ; Liao SL; Su HL; Chen CJ J Neurochem; 2012 Oct; 123(2):250-61. PubMed ID: 22845610 [TBL] [Abstract][Full Text] [Related]
25. Evidence for latency of Japanese encephalitis virus in T lymphocytes. Mathur A; Kulshreshtha R; Chaturvedi UC J Gen Virol; 1989 Feb; 70 ( Pt 2)():461-5. PubMed ID: 2543749 [TBL] [Abstract][Full Text] [Related]
26. Alteration in immune response of mice with dual infection of Toxocara canis and Japanese encephalitis virus. Gupta AK; Pavri KM Trans R Soc Trop Med Hyg; 1987; 81(5):835-40. PubMed ID: 2835835 [TBL] [Abstract][Full Text] [Related]
27. Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. Burke DS; Nisalak A; Ussery MA; Laorakpongse T; Chantavibul S J Infect Dis; 1985 Jun; 151(6):1093-9. PubMed ID: 2987367 [TBL] [Abstract][Full Text] [Related]
28. Induction of secondary immune response by reactivated Japanese encephalitis virus in latently infected mice. Mathur A; Kulshreshtha R; Chaturvedi UC Immunology; 1987 Apr; 60(4):481-4. PubMed ID: 3034766 [TBL] [Abstract][Full Text] [Related]
29. Development of a recombinant vaccine against Japanese encephalitis. Kaur R; Vrati S J Neurovirol; 2003 Aug; 9(4):421-31. PubMed ID: 12907387 [TBL] [Abstract][Full Text] [Related]
30. Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus. Cao L; Fu S; Gao X; Li M; Cui S; Li X; Cao Y; Lei W; Lu Z; He Y; Wang H; Yan J; Gao GF; Liang G PLoS Negl Trop Dis; 2016 May; 10(5):e0004686. PubMed ID: 27139722 [TBL] [Abstract][Full Text] [Related]
31. Modulation of the immune-related gene responses to protect mice against Japanese encephalitis virus using the antimicrobial peptide, tilapia hepcidin 1-5. Huang HN; Rajanbabu V; Pan CY; Chan YL; Hui CF; Chen JY; Wu CJ Biomaterials; 2011 Oct; 32(28):6804-14. PubMed ID: 21726898 [TBL] [Abstract][Full Text] [Related]
32. Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus. Saga R; Fujimoto A; Watanabe N; Matsuda M; Hasegawa M; Watashi K; Aizaki H; Nakamura N; Tajima S; Takasaki T; Konishi E; Kato T; Kohara M; Takeyama H; Wakita T; Suzuki R Sci Rep; 2016 Jun; 6():28688. PubMed ID: 27345289 [TBL] [Abstract][Full Text] [Related]
33. Immunomodulatory cytokines determine the outcome of Japanese encephalitis virus infection in mice. Biswas SM; Kar S; Singh R; Chakraborty D; Vipat V; Raut CG; Mishra AC; Gore MM; Ghosh D J Med Virol; 2010 Feb; 82(2):304-10. PubMed ID: 20029807 [TBL] [Abstract][Full Text] [Related]
34. An enzyme immunoassay for detection of Japanese encephalitis virus-induced chemotactic cytokine. Singh A; Kulshreshtha R; Mathur A J Biosci; 2000 Mar; 25(1):47-55. PubMed ID: 10824198 [TBL] [Abstract][Full Text] [Related]
35. Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor. Zhai Y; Zhou Y; Li X; Feng G Mol Med Rep; 2015 Jul; 12(1):199-209. PubMed ID: 25738258 [TBL] [Abstract][Full Text] [Related]
36. The chimeric Japanese encephalitis/Dengue 2 virus protects mice from challenge by both dengue virus and JEV virulent virus. Yang J; Yang H; Li Z; Lin H; Zhao Y; Wang W; Tan S; Zeng X; Li Y Protein Cell; 2017 Mar; 8(3):225-229. PubMed ID: 28124229 [No Abstract] [Full Text] [Related]
37. Japanese encephalitis virus-infected macrophages induce neuronal death. Nazmi A; Dutta K; Das S; Basu A J Neuroimmune Pharmacol; 2011 Sep; 6(3):420-33. PubMed ID: 21424747 [TBL] [Abstract][Full Text] [Related]
38. Suppressor T cells for delayed-type hypersensitivity to Japanese encephalitis virus. Mathur A; Rawat S; Chaturvedi UC Immunology; 1984 Jul; 52(3):395-402. PubMed ID: 6204929 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of Japanese encephalitis virus infection by the host zinc-finger antiviral protein. Chiu HP; Chiu H; Yang CF; Lee YL; Chiu FL; Kuo HC; Lin RJ; Lin YL PLoS Pathog; 2018 Jul; 14(7):e1007166. PubMed ID: 30016363 [TBL] [Abstract][Full Text] [Related]
40. Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. Kimura-Kuroda J; Yasui K J Immunol; 1988 Nov; 141(10):3606-10. PubMed ID: 2460542 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]